Alumis (NASDAQ: ALMS) insider funds report $17 common stock share buys
Rhea-AI Filing Summary
Alumis Inc. (ALMS) received a Form 4 filing from several Foresite Capital and Foresite Labs investment entities that are 10% owners, reporting indirect ownership of Alumis common stock.
On January 8, 2026, Foresite Capital Fund V, L.P. purchased 117,647 Alumis common shares at $17 per share, bringing its indirectly reported holdings to 5,702,536 shares. On the same date, Foresite Capital Opportunity Fund V, L.P. purchased 294,117 shares at $17 per share, with indirectly reported holdings of 2,908,332 shares.
The filing also lists additional indirect common stock holdings: Foresite Capital Fund VI, L.P. with 4,247,670 shares, Labs Co-Invest V, LLC with 194,459 shares, Foresite Labs Fund I, L.P. with 1,960,337 shares, and Foresite Labs Affiliates 2021, LLC with 1,176,470 shares. The reporting entities note that they may be deemed to have voting and dispositive power through their general partners or managing members and each disclaims group status and beneficial ownership beyond its pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 117,647 | $17.00 | $2.00M |
| Purchase | Common Stock | 294,117 | $17.00 | $5.00M |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- The shares are held of record by Foresite Capital Fund V, L.P. ("Fund V"). Foresite Capital Management V, LLC ("FCM V") is the general partner of Fund V and may be deemed to have sole voting and dispositive power over such shares. James B. Tananbaum ("Tananbaum"), the managing member of FCM V, may be deemed to have sole voting and dispositive power over such shares. Each of the Reporting Persons disclaims the existence of a "group", as defined in Rule 13d-5 of the Exchange Act, and, other than Fund V, disclaims beneficial ownership of the shares held by Fund V, except to the extent of such person's pecuniary interest in such securities. The shares are held of record by Foresite Capital Opportunity Fund V, L.P. ("Opportunity Fund V"). Foresite Capital Opportunity Management V, LLC ("FCOM V") is the general partner of Opportunity Fund V and may be deemed to have sole voting and dispositive power over such shares. Tananbaum, the managing member of FCOM V, may be deemed to have sole voting and dispositive power over such shares. Each of the Reporting Persons disclaims the existence of a "group", as defined in Rule 13d-5 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and, other than Opportunity Fund V, disclaims beneficial ownership of the shares held by Opportunity Fund V, except to the extent of such person's pecuniary interest in such securities. The shares are held of record by Foresite Capital Fund VI, L.P. ("Fund VI"). Foresite Capital Management VI, LLC ("FCM VI") is the general partner of Fund VI and may be deemed to have sole voting and dispositive power over such shares. Tananbaum, the managing member of FCM VI, may be deemed to have sole voting and dispositive power over such shares. Each of the Reporting Persons disclaims the existence of a "group", as defined in Rule 13d-5 of the Exchange Act, and, other than Fund VI, disclaims beneficial ownership of the shares held by Fund VI, except to the extent of such person's pecuniary interest in such securities. The shares are held of record by Labs Co-Invest V, LLC ("Labs Co-Invest"). FCM V is the managing member of Labs Co-Invest and may be deemed to have sole voting and dispositive power over such shares. Tananbaum, the managing member of FCM V, may be deemed to have sole voting and dispositive power over such shares. Each of the Reporting Persons disclaims the existence of a "group", as defined in Rule 13d-5 of the Exchange Act, and, other than Labs Co-Invest, disclaims beneficial ownership of the shares held by Labs Co-Invest, except to the extent of such person's pecuniary interest in such securities. The shares are held of record by Foresite Labs Fund I, L.P. ("Labs Fund I"). Foresite Labs Management I, LLC ("FLM I") is the general partner of Labs Fund I and may be deemed to have sole voting and dispositive power over such shares. Tananbaum, the managing member of FLM I, may be deemed to have sole voting and dispositive power over such shares. Each of the Reporting Persons disclaims the existence of a "group", as defined in Rule 13d-5 of the Exchange Act, and, other than Labs Fund I, disclaims beneficial ownership of the shares held by Labs Fund I, except to the extent of such person's pecuniary interest in such securities. The shares are held of record by Foresite Labs Affiliates 2021, LLC ("Labs Affiliates"). Foresite Labs, LLC ("Labs") is the managing member of Labs Affiliates and may be deemed to have sole voting and dispositive power over such shares. Tananbaum, a manager of Labs, may be deemed to share voting and dispositive power over such shares. Each of the Reporting Persons disclaims the existence of a "group", as defined in Rule 13d-5 of the Exchange Act, and, other than Lab Affiliates, disclaims beneficial ownership of the shares held by Labs Affiliates, except to the extent of such person's pecuniary interest in such securities.
FAQ
What insider activity did Alumis (ALMS) report in this Form 4?
The Form 4 reports that Foresite Capital and Foresite Labs investment entities, each a 10% owner of Alumis Inc., updated their indirect holdings of Alumis common stock, including two open-market purchases on January 8, 2026 at $17 per share.
Are these Alumis (ALMS) holdings direct or indirect for the reporting entities?
All positions in the table are reported as indirect (I) ownership, with the nature of ownership described in the footnotes, which attribute share ownership to specific funds and LLCs that hold the shares of record.